GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Shivalik Rasayan Ltd (NSE:SHIVALIK) » Definitions » ROE % Adjusted to Book Value

Shivalik Rasayan (NSE:SHIVALIK) ROE % Adjusted to Book Value : 1.76% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shivalik Rasayan ROE % Adjusted to Book Value?

Shivalik Rasayan's ROE % for the quarter that ended in Sep. 2024 was 3.16%. Shivalik Rasayan's PB Ratio for the quarter that ended in Sep. 2024 was 1.80. Shivalik Rasayan's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 1.76%.


Shivalik Rasayan ROE % Adjusted to Book Value Historical Data

The historical data trend for Shivalik Rasayan's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shivalik Rasayan ROE % Adjusted to Book Value Chart

Shivalik Rasayan Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 2.34 2.23 1.57

Shivalik Rasayan Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 - 1.60 - 1.76

Competitive Comparison of Shivalik Rasayan's ROE % Adjusted to Book Value

For the Agricultural Inputs subindustry, Shivalik Rasayan's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shivalik Rasayan's ROE % Adjusted to Book Value Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Shivalik Rasayan's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Shivalik Rasayan's ROE % Adjusted to Book Value falls into.



Shivalik Rasayan ROE % Adjusted to Book Value Calculation

Shivalik Rasayan's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=3.63% / 2.31
=1.57%

Shivalik Rasayan's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=3.16% / 1.80
=1.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shivalik Rasayan ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Shivalik Rasayan's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Shivalik Rasayan Business Description

Traded in Other Exchanges
Address
1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, IND, 110 019
Shivalik Rasayan Ltd is an Indian manufacturer of Agrochemicals and Active Pharma Ingredients (API). The company's business units cover Pharmaceuticals, Agrochemicals, Intellectual property, and R&D centers. The company derives revenue from the manufacture and export of pharmaceutical products.

Shivalik Rasayan Headlines

No Headlines